Kanamycin – Injection Products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
| Minimum Inhibitory | Disk Diffusion | ||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Enterobacteriaceae | M100 standard is recognized | |||||
Staphylococcus aureus | ≤ 16 | 32 | ≥ 64 | ≥ 18 | 14-17 | ≤ 13 |
S = Susceptible; I = Intermediate; R = Resistant